Relief Ordered for FDA "Regulatory Review Officer" Fired for Blowing the Whistle on Unsafe Breast Cancer Detection Device
Washington, D.C. October 19, 2010. The Merit Systems Protection Board (MSPB) allowed a stay requested by the U.S. Office of Special Counsel on behalf of a Food and Drug Administration (FDA) whistleblower, Paul T. Hardy. Under the provisions of the Whistleblower Protection Act, this stay should result in Hardy's immediate reinstatement into federal service after his managers at the FDA orchestrated his termination on October 9, 2011.
Washington, D.C. September 9, 2011. Today, the Government Accountability Office (GAO) released a report on the IRS whistleblower program. The IRS whistleblower program was created to help the IRS collect an estimated $345 billion yearly in unpaid taxes. Since 2007, over 1,300 whistleblowers have filed claims with the IRS Whistleblower Office alleging tax fraud (in excess of $2 million) against 9,540 "taxpayers." The IRS is still investigating 8,254 (86.5%) "taxpayers" for tax fraud.
Washington D.C. August 4, 2011. Today, the Commodity Futures
Trading Commission (CFTC) voted 4-1 to approve the Final Rules implementing the
whistleblower provisions in the Dodd-Frank Wall Street Reform and Consumer
Protection Act. The rules will have a major impact on the ability of
individuals to report corporate fraud and protect the integrity of financial